Ferring Pharmaceuticals’ Post

We're honored to announce that our Spain PRO-WAVE1 study on monitoring patient-reported outcomes (PROs) in prostate cancer earned a prestigious poster presentation at the 2024 European Multidisciplinary Congress on Urological Cancers (EMUC) in Lisbon, Portugal! 🇵🇹 This weekend we shared key findings from our 8-clinic study, where we identified critical symptom clusters — such as sad feelings, pain, and constipation — that strongly impact patients’ quality of life. Using Dynamic Time Warping (DTW) analysis, we presented patterns that may help develop targeted, multi-symptom treatment plans to enhance patient care and improve health outcomes. Learn more about the poster and results: 🔗 https://lnkd.in/gq6DVvPT #EMUC2024 #WaveHealth #ProstateCancer #DigitalHealth #ePROs

UROonco24 will take place in the historic city of Budapest, Hungary, from 14:00 on Thursday 20 June, until 15:00 on Saturday 22 June 2024. This European onco-urology meeting represents a dynamic learning platform where experts and delegates can share knowledge, deliberate on the latest research, and pave the way together to improve patient outcomes. ESOU board members Dr. Gianluca Giannarini (IT) and Dr. Maria Carmen Mir Maresma (ES) share some details of the critical issues and promising developments in the field of GU cancers that are in the scientific programme this year. Insights from Dr. Giannarini: “Prostate cancer sessions will cover the whole spectrum of the disease. This year, there will be a special focus on the management of biochemical recurrence and persistence after radical prostatectomy, and of oligometastatic disease detected with PSMA PET imaging, as well as on novel strategies of treatment intensification and combination in the overt metastatic hormone-sensitive and castration-resistant setting.” Read more here: https://lnkd.in/evrG7WcE

Dense breasts, which are more likely to present in Asian women compared to Caucasian women, is a risk factor for developing breast cancer. Recently, a team led by Professor Kartini Rahmat conducted the first Association of Southeast Asian Nations (ASEAN) study of ABUS designed to assess the performance of the Invenia™ ABUS as an adjunct to digital breast tomosynthesis (DBT). Read the results in the GE HealthCare Insights story: https://lnkd.in/gisrupii 1-Kartini Rahmat, et.al., Automated Breast Ultrasound Provides Comparable Diagnostic Performance in Opportunistic Screening and Diagnostic Assessment. Ultrasound in Medicine & Biology. 2023. https://lnkd.in/gCCimWeC #GEHealthCare #ABUS #Mammography #Invenia #BreastUltrasound #Breastcancer #Densebreasts #Ultrasound

Dense breasts, which are more likely to present in Asian women compared to Caucasian women, is a risk factor for developing breast cancer. Recently, a team led by Professor Kartini Rahmat conducted the first Association of Southeast Asian Nations (ASEAN) study of ABUS designed to assess the performance of the Invenia™ ABUS as an adjunct to digital breast tomosynthesis (DBT). Read the results in the GE HealthCare Insights story: https://lnkd.in/es_wEGyk 1-Kartini Rahmat, et.al., Automated Breast Ultrasound Provides Comparable Diagnostic Performance in Opportunistic Screening and Diagnostic Assessment. Ultrasound in Medicine & Biology. 2023. https://lnkd.in/e9AjuvPs #GEHealthCare #ABUS #Mammography #Invenia #BreastUltrasound #Breastcancer #Densebreasts #Ultrasound

Please join this exciting Webinar - "Edge of Innovation in Radiosurgery"

We were excited to see the posts recently from the European Association of Urology and Ipsen on their newest resources supporting shared decision making in kidney cancer care. Shared decision making between patients with kidney cancer and their healthcare team optimizes patient outcomes and quality of life. Patients, carers, and health care professionals developed with IPSEN a Shared Decision Making Action Plan for kidney cancer: https://lnkd.in/gBAPyz_R In addition, EAU recently released a shared decision making video: https://lnkd.in/gUANUsE6 Complimenting these important new resources, My Treatment, My Choice, IKCC shared decision guides are available at https://lnkd.in/gAhRhX9U #KidneyCancer

Dense breasts, which are more likely to present in Asian women compared to Caucasian women, is a risk factor for developing breast cancer. Recently, a team led by Professor Kartini Rahmat conducted the first Association of Southeast Asian Nations (ASEAN) study of ABUS designed to assess the performance of the Invenia™ ABUS as an adjunct to digital breast tomosynthesis (DBT). Read the results in the GE HealthCare Insights story: https://lnkd.in/eWcKmKNQ 1-Kartini Rahmat, et.al., Automated Breast Ultrasound Provides Comparable Diagnostic Performance in Opportunistic Screening and Diagnostic Assessment. Ultrasound in Medicine & Biology. 2023. https://lnkd.in/ewMt3vTS #GEHealthCare #ABUS #Mammography #Invenia #BreastUltrasound #Breastcancer #Densebreasts #Ultrasound

Dense breasts, which are more likely to present in Asian women compared to Caucasian women, is a risk factor for developing breast cancer. Recently, a team led by Professor Kartini Rahmat conducted the first Association of Southeast Asian Nations (ASEAN) study of ABUS designed to assess the performance of the Invenia™ ABUS as an adjunct to digital breast tomosynthesis (DBT). Read the results in the GE HealthCare Insights story: https://lnkd.in/gfUSiujm 1-Kartini Rahmat, et.al., Automated Breast Ultrasound Provides Comparable Diagnostic Performance in Opportunistic Screening and Diagnostic Assessment. Ultrasound in Medicine & Biology. 2023. https://lnkd.in/g7Ah9whN #GEHealthCare #ABUS #Mammography #Invenia #BreastUltrasound #Breastcancer #Densebreasts #Ultrasound

Dense breasts, which are more likely to present in Asian women compared to Caucasian women, is a risk factor for developing breast cancer. Recently, a team led by Professor Kartini Rahmat conducted the first Association of Southeast Asian Nations (ASEAN) study of ABUS designed to assess the performance of the Invenia™ ABUS as an adjunct to digital breast tomosynthesis (DBT). Read the results in the GE HealthCare Insights story: https://lnkd.in/gXNxc9RW 1-Kartini Rahmat, et.al., Automated Breast Ultrasound Provides Comparable Diagnostic Performance in Opportunistic Screening and Diagnostic Assessment. Ultrasound in Medicine & Biology. 2023. https://lnkd.in/gDcu-yMA #GEHealthCare #ABUS #Mammography #Invenia #BreastUltrasound #Breastcancer #Densebreasts #Ultrasound

Here are the highlights from my talk last week at Digestive Disease Week® (DDW) on #pancreaticcancer #screening: • Pancreatic #cancer represents 3% of cancers and 8% of cancer related mortality •5 year survival rate of continues to be a dismal 10% • While the quality of evidence is low, screening is associated with: - psychological benefit - Yield of screening whether MRI or #EUS is used is 3 to 4% so the majority test negative - Patients diagnosed during screening have a 3 year survival of 85% as opposed to 25% of those diagnosed with symptoms - there is almost half however who has surgery without having a high risk lesion at the cost of around 20% adverse event rate - circulating tumor DNA based assay leveraging the power of #precisionmedicine and #artificialintelligence are rapidly improving and promise to change the landscape.